Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Erythropoietin on AKI Following Complex Valvular Heart Surgery
NCT01758861Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Jul 2011
- Primary completion
- Sep 2012
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute kidney injury (AKI) comparing EPO group with Placebo group (2 arms). Primary endpoint: Incidence of Acute Kidney Injury. Started Jul 2011; status: completed.
02
Drugs
epoetin alfa
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT01758861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01758861.